LATE RECTAL COMPLICATIONS IN PATIENTS WITH CARCINOMA OF THE CERVIX TREATED WITH RADIOTHERAPY ALONE
Abstract
Purpose: To evaluate the frequency and severity of late rectal complications in cervical cancer patients treated with radiotherapy alone, combination of external beam irradiation and high dose rate intracavitary radiation, at Section of Radiation Oncology, Faculty of Medicine, Chiang Mai University and to assess the correlation between the biological effective dose (BED) to the rectum and the development of late rectal complications.
Materials and Methods: Between January 1995 and June 1997, 76 patients with cervical cancer stage IB to IIIB treated with radiotherapy alone were included. Radiotherapy consisted of 40-60 Gy external beam radiation plus 4-6 high dose rate intracavitary to a total dose of approximately 30 Gy to point A, defined as 2 cm. above the external os and 2 cm. lateral to the axis of the intrauterine tube. Patient characteristics, radiation parameters and symptoms of late rectal complications were collected from the medical records. Severity of late rectal complications were clinically graded according to RTOG late morbididity grading scheme and endoscopically graded according to Gilinsky classification. Correlation between clinical and endoscopic grading, biological effective dose and late rectal complications were assessed.
Results: With a median follow up time of 13 months, the overall rate of late rectal complications (RTOG grade 1-4) was 34% (26 (26 of 76 patients). The median time for development of complications was 9 months after completion of treatment. Twelve percent of patients had high grade late rectal complications (RTOG grade 3, 4). All patients who were selected for sigmoidoscopy had histologically proven for radiation proctitis. Clinical RTOG grading significantly correlated with endoscopically grading. The correlation between the biological effective dose delivered to the rectal reference point and the development of late rectal complications shows a strong dose-response with a threshold for complications occurring at approximately 100 Gy3 and a complication probability of 30%.
Conclusion: This investigation revealed a significant correlation between the biological effective dose and the development of late rectal complications in patients with carcinoma of the cervix undergoing radiotherapy alone. Using the linear-quadratic model applied for our clinical results, we have established a threshold for the incidence of late rectal complication. The threshold is consistent with other studies.
References
Barendsen, G.W. Dose fractionation, dose rate and iso-effect relationships for normal tissue responses, Int. J. Radiat. Oncol. Biol. Phys. 8: 1981-1997;1982.
Bloomer WD. Human normal tissue response to radiation therapy. N. Eng. J. Med.; 293:80-83; 1975.
Carlos A. Perez. Overview : Principal and Practical of radiation Oncology 53-55; New York 1992.
Carlos A. Perez; Perry w. Grigsby ; Herman Castro-Vita; Mary Ann Lodcett. Carcinoma of the Uterine cervix II: Lack of Impact of Prolongation of overall treatment time on Morbidity of Radiation Therapy. Int. J. Radiat. Oncol. Biol. Phys. 34 (1) : 3-11 ; 1996.
Chen, M.S.; Lin, EJ.; Hong, C.H.; Tu, C.P.; Lan, J.H.; Tang, S.G.; Leung, W.M.; Wang, T.R. High dose rate afterloading technique in the radiation treatment of uterine cervical cancer: 399 cases and 9 years experience in Taiwan. Int. J. Radiat. Oncol. Biol. Phys. 20: 915-919; 1991.
ChiangMai Cancer Registry, Annual Report 1994 Vol. 17 Cancer Unit MMaharaj Nakom Chiang Mai Hospital, Faculty of Medicine, Chiang Mai Uuniversity, Chiang Mai, Thailand.
Chong, J.W.; Stephen W.L; Hui, C.C.; Li, M.S.; Fu, M.F.; Eng. Y.H.; Ching, Y.H.; Chan, C.C. The correlation of acute toxicity and late rectal injury in radiotherapy for cervical carcinoma: Evidence suggestive of consequential late effect (CQLE). Int. J. Radiat. Oncol. Biol. Phys. 40 (1): 85-91, 1998.
Clark, B.G.; Souhami, L.; Roman, T.N.; Evans, M.D.; Chappell, R.; Fowler, J.F. The prediction of late rectal complications in patients treated with high dose-rate brachytherapy for carcinoma of the cervix. Int. J. Radiat. Oncol. Biol. Phys. 38 (5) 989-993; 1997.
Clark, B.G.; Souhami, L.; Roman, T.N.; Evans, M.D; Pla, C. Rectal Complication in Patients with carcinoma of the cervix treated with concomitant cisplatin and external beam irradiation with High Dose Rate brachytherapy: A dosimetric analysis. Int. J. J. Radiat. Oncol. Biol. Phys. 28 (5) 1243-1250; 1994.
Fowler ,J.F. Brief summary of radiobiological principles in fractionated radiotherapy. Semin. Radiat. Oncol. 2:16-21; 1992.
Fowler, J.F. ; stern, B.E. Dose-time relationships in radiotherapy and the validity of cell survival models. Br.J. Radiol, 36:163-173; 1963.
Gilinsky N.H.; Burns G. The natural history of radiation induced proctosigmoiditis. QJ Med; 205:40-53; 1983.
Goldstein F. , Khoury J, Thonton J.T. Treatment of chronic radiation enteritis and colitis with salicylazosulfapyridine and systemic corticosteroid. Am. Gastroenterol.; 65: 201-208 1976.
John Curtin; Rachelle M.L.; Andrzej P.K.: Cancer Management: A multidisciplinary Approach. p 142-163; New York ; 1996.
Novak J.M, Collins IT, Donowitz M, et al. Effects of radiation on the human gastrointestinal tract. J. Clin. Gastroenterol.; 1:9-39 ; 1979.
Ogino, I.; Kitamura, T.; okamoto, N.; Yamasita, K.; Aikawa, Y.; Okajima, H.; Matsubara, S. Late rectal complication following high dose rate intracavitary brachytherapy in cancer of the cervix. Int. J. Radiat. Oncol. Biol. Phys. 31: 725-734; 1995.
Roman, T.N; Souhami, L.; Freeman, C.R.; Pla, C.; Evans, M.D.C.; Podgorsak, E.B.; Mendelew, K. High dose rate afterloading intracavitary therapy in carcinoma of the cervix. Int. J. Radiat. Oncol. Biol. Phys. 20: 921-926; 1991.
Shu-Mo, C.; Xiang-E.W.; Qi, W. High dose rate afterloading-in the treatment of cervical cancer of the uterus. Int. J. Radiat. Oncol. Biol. Phys. 16: 335-338; 1989.
Walsh D. Deep tissue trauma from Roentgen Ray exposure. Br. Med. J. ; 2: 272-273; 1897.
Wang, C.J. Leung, S.W.; Chen H.C.; Sun, LM.; Fang, F.M.; Changchien, C.C.; Huang, E.Y.; Wu, J.M.; Chen, C.C. High dose rate intracavitary brachytherapy (HDR-IC) in treatment of cervical cancer: 5-year results and implication of increased low-grade rectal complicatin of initiation an HDR-IC fractionation scheme. Int. I. Radiat. Oncol. Biol. Phys. 38: 391-398; 1997.
Downloads
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
บทความที่ได้รับการตีพิมพ์เป็นลิขสิทธิ์ของวารสารมะเร็งวิวัฒน์ ข้อความที่ปรากฏในบทความแต่ละเรื่องในวารสารวิชาการเล่มนี้เป็นความคิดเห็นส่วนตัวของผู้เขียนแต่ละท่านไม่เกี่ยวข้องกับ และบุคคลากรท่านอื่น ๆ ใน สมาคมฯ แต่อย่างใด ความรับผิดชอบองค์ประกอบทั้งหมดของบทความแต่ละเรื่องเป็นของผู้เขียนแต่ละท่าน หากมีความผิดพลาดใดๆ ผู้เขียนแต่ละท่านจะรับผิดชอบบทความของตนเองแต่ผู้เดียว
